Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02146066
Title Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Acronym DCVax-L EAP
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Northwest Biotherapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.